Geographical Variation in Antimalarial Drug Resistance Marker Prevalence across the Southern African Elimination Eight Region
The American Journal of Tropical Medicine and Hygiene · 03.11.2026 · 115 (5_Suppl) · 5-18
DOI: 10.4269/ajtmh.26-0299 ↗Kurz gefasst
Fachartikel in der Zeitschrift The American Journal of Tropical Medicine and Hygiene, erschienen am 03.11.2026. Verfasst von Jaishree Raman und 43 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for Antimalarial Resistance Monitoring and Malaria Operational Research, Centre of Emerging Zoonotic and Parasitic Diseases, National Inst…. Hauptthemen laut MEDLINE: Antimalarials, Plasmodium falciparum, Drug Resistance, Malaria, Falciparum. Die Arbeit nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Bill & Melinda Gates Foundation.
Abstract (Originalsprache)
Global efforts to control and eliminate malaria are threatened by antimalarial drug resistance. The WHO recommends molecular surveillance of resistance markers as a complementary approach to therapeutic efficacy studies. Here, the first regional analysis of antimalarial resistance markers across six southern African countries spanning diverse transmission intensities and geographies is reported. Dried blood spots, collected from rapid diagnostic test-positive individuals in Angola, Eswatini, Namibia, and Zambia in 2023, Mozambique in 2022, and South Africa between 2022 and 2024 using a standardized collection method, were analyzed using a Plasmodium falciparum -targeted amplicon sequencing protocol. The distribution of resistance markers was spatially heterogeneous. Validated markers of artemisinin partial resistance (ART-R) were rare. However, more than 30% of samples from eastern Namibia and Zambia’s Western and Central Provinces carried the candidate kelch13 P441L ART-R marker. Other ART-R markers ( kelch13 R515K, P553L, P574L, A675V) were detected at a prevalence rate 99%) across all countries, whereas the chloroquine resistance marker K76T, in the chloroquine resistance transporter ( crt ) was nearly absent in most districts. The sulfadoxine–pyrimethamine resistance dihydropteroate synthase ( dhps )-dihydrofolate reductase quintuple mutation was approaching fixation (>95%) in 35% of districts. Northern Angola was a clear outlier, with a lower dhps K540E prevalence (≤20%) but a higher crt K76T prevalence (48% to 56%). This pronounced spatial heterogeneity underscores the need for timely high-resolution local resistance data generation and sharing to safeguard antimalarial drug efficacy and guide malaria control and elimination strategies across the region.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory for Antimalarial Resistance Monitoring and Malaria Operational Research, Centre of Emerging Zoonotic and Parasitic Diseases, National Institute for Communicable Diseases, Johannesburg, South Africa.
- Wits Research Institute for Malaria, University of Witwatersrand, Johannesburg, South Africa.
- University of Pretoria Institute for Sustainable Malaria Control, University of Pretoria, Pretoria, South Africa.
- EPPIcenter Research Program, Department of Medicine, University of California, San Francisco, California, USA.
- Malaria Elimination Initiative, Global Health Group, University of California, San Francisco, California, USA.
- ISGlobal, Barcelona, Spain.
Förderung
- NIAID NIH HHS
- Bill & Melinda Gates Foundation
Zitieren
APA
Raman, J., Aranda-Díaz, A., Mabona, M., Chisenga, M., João, M. F., Jandondo, D., Dimbu, P. R., Nhlengethwa, N., Dlamini, S. V., Eloff, L., Katokele, S., Mumbengegwi, D. R., Nyawo, Q., Shandukani, M., Mwanza, S., Hawela, M., Boene, S., Chidimatembue, A., Rafael, B., …, & Smith, J. L. (2026). Geographical Variation in Antimalarial Drug Resistance Marker Prevalence across the Southern African Elimination Eight Region. The American Journal of Tropical Medicine and Hygiene, 115(5_Suppl), 5-18. https://doi.org/10.4269/ajtmh.26-0299
Vancouver
Raman J, Aranda-Díaz A, Mabona M, Chisenga M, João MF, Jandondo D, et al. Geographical Variation in Antimalarial Drug Resistance Marker Prevalence across the Southern African Elimination Eight Region. The American Journal of Tropical Medicine and Hygiene. 2026;115(5_Suppl):5-18. doi:10.4269/ajtmh.26-0299
BibTeX
@article{Raman2026,
author = {Raman, Jaishree and Aranda-Díaz, Andrés and Mabona, Maxwell and Chisenga, Mukosha and João, Maria Florinda and Jandondo, Domingos and Dimbu, Pedro Rafael and Nhlengethwa, Nomcebo and Dlamini, Sabelo V and Eloff, Lydia and Katokele, Stark and Mumbengegwi, Davis R and Nyawo, Qedusizi and Shandukani, Mbavhalelo and Mwanza, Sydney and Hawela, Moonga and Boene, Simone and Chidimatembue, Arlindo and Rafael, Bernardete and Rovira-Vallbona, Eduard and Mangena, Brighton and Lauterbach, Sonja B and Makhanthisa, Takalani I and Gwarinda, Hazel and Letinić, Blaženka D and De Amaral, Faith and Routledge, Isobel and Arregui-Gallego, Beatriz and Moodley, Mishalan and Featherston, Jonathan and Tshikae, Power B and Ismail, Arshad and Martins, Jose Franco and Dlamini, Quinton and Candrinho, Baltazar and Uusiku, Petrina and Baloyi, Ednah and Hamainza, Busiku and Mayor, Alfredo and Greenhouse, Bryan and Wesolowski, Amy and Sikaala, Chadwick and Chimumbwa, John and Smith, Jennifer L},
title = {Geographical Variation in Antimalarial Drug Resistance Marker Prevalence across the Southern African Elimination Eight Region},
journal = {The American Journal of Tropical Medicine and Hygiene},
year = {2026},
volume = {115},
number = {5_Suppl},
pages = {5--18},
doi = {10.4269/ajtmh.26-0299}
}
EUVIMED